Surmodics (Nasdaq:SRDX) announced results from a sex-specific analysis of real-world patients in a study of its Pounce thrombectomy system. The analysis evaluated 160 acute, subacute and chronic thrombotic limb ischemia patients from the PROWL registry. Dr. Peter Monteleone presented findings at the 2025 Transcatheter Cardiovascular Therapeutics … [Read more...] about Surmodics reports real-world Pounce thrombectomy system findings
Nitinol
Zenflow gets FDA nod for single-use cystoscope
Zenflow announced today that it received FDA 510(k) clearance for its Spring scope and camera control unit (CCU). The South San Francisco, California-based company touts its Spring scope and CCU as the first single-use cystoscope of its kind. It features a 12-fr working channel, making it more than 80% larger than current single-use models, the … [Read more...] about Zenflow gets FDA nod for single-use cystoscope
ProVerum raises $80M for nitinol stent that treats BPH
ProVerum announced today that it closed an $80 million Series B equity financing to support its device to treat benign prostatic hyperplasia (BPH). MVM Partners led the financing. New investors OrbiMed and the Ireland Strategic Investment Fund (ISIF) also joined in. Existing investors Gilde Healthcare Partners, Lightstone Ventures, Atlantic Bridge … [Read more...] about ProVerum raises $80M for nitinol stent that treats BPH
Second Heart Assist adds investment firm veteran to board
Second Heart Assist announced that it appointed Bill Carpou to its board of directors as it prepares to scale its cardio-renal platform. Carpou currently serves as CEO of Octane, a leading growth platform for medical technology companies. He previously held a senior operating role with Blackstone, the world's largest alternative investment … [Read more...] about Second Heart Assist adds investment firm veteran to board
Surmodics launches Pounce XL thrombectomy system
Surmodics (Nasdaq:SRDX) announced today that it commercially launched the Pounce XL thrombectomy system for clot removal. Pounce XL joins the larger suite of Pounce thrombectomy systems. They offer rapid endovascular removal of acute or chronic clot from peripheral arteries. Eden Prairie, Minnesota-based Surmodics designed Pounce to enable … [Read more...] about Surmodics launches Pounce XL thrombectomy system
Stryker’s Inari Medical launches Artix thrombectomy system
Inari Medical — now part of Stryker — announced that it launched its Artix thrombectomy system for arterial thrombectomies. The company built Artix for the distinct needs of the peripheral arterial system, according to a news release. It marks Inari's inaugural entry into the arterial space. The combined aspiration plus mechanical … [Read more...] about Stryker’s Inari Medical launches Artix thrombectomy system
CereVasc study data backs eShunt system
CereVasc today announced initial results from a pilot clinical study supporting the use of its eShunt system. Boston-based CereVasc designed eShunt for treating normal pressure hydrocephalus (NPH). This study evaluates the technology in the treatment of elderly patients with NPH. eShunt has FDA breakthrough device designation, which it picked up … [Read more...] about CereVasc study data backs eShunt system
Surmodics reports first clinical use of thrombectomy system
Surmodics (Nasdaq:SRDX) today announced the successful early clinical use of its Pounce XL thrombectomy system. The early use comes as part of a limited market release. Surmodics plans for a full commercial launch planned for after the initial rollout. Pounce XL received FDA 510(k) clearance in September 2024. Dr. Walter Rizzoni used the system … [Read more...] about Surmodics reports first clinical use of thrombectomy system
FDA approves Merit Medical’s cell-impermeable endoprosthesis
Merit Medical Systems (Nasdaq:MMSI) announced today that it received FDA premarket approval for its Wrapsody cell-impermeable endoprosthesis. With approval, the company can begin commercializing the device in the U.S. in 2025. South Jordan, Utah–based Merit Medical designed Wrapsody to extend long-term vessel patency in dialysis patients. It … [Read more...] about FDA approves Merit Medical’s cell-impermeable endoprosthesis
First Look: Flow Medical’s next-generation thrombolysis catheter for pulmonary embolism
Flow Medical is developing a thrombolysis catheter to improve the treatment of blood clots in pulmonary embolism patients. The Chicago-based startup designed its minimally invasive system with a novel nitinol scaffold that perforates blood clots and infuses them with tissue plasminogen activator (TPA), a thrombolytic drug commonly referred to as … [Read more...] about First Look: Flow Medical’s next-generation thrombolysis catheter for pulmonary embolism
